Alectinib boosts anti-tumor efficacy of disialoganglioside 2 chimeric antigen receptor T cells in ALK-mutated neuroblastoma by suppressing programmed death-ligand 1
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Fields of Study & Subjects
Publication details
- Journal / source
- British Journal of Cancer
- Volume
- 134
- Issue
- 10
- Pages
- 1488–1496
- Publication date
- 23 March 2026
- Language
- EN